Part B Demo Concerns Unite Policy Experts Across Political Spectrum
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Democratic congressional staffers agree with Republican health policy experts there is little to like about the proposed Medicare Part B drug payment demonstration.
You may also be interested in...
Gottlieb Joins HHS Transition Team; Will Next Stop Be FDA?
Former US FDA, CMS official has been among those thought to be in the running for Trump's FDA commissioner nomination.
Romney’s Top Policy Strategist Brings Early Interest In Health Care, Part D
Lanhee Chen’s track record includes multiple national political campaigns and analysis of Part D legislation and health reform during think-tank fellowships.
Medicare "Least Costly Alternative" Nixed By Courts, But Could Reform Bill's IMAB Convey New Authority?
A federal appeals court has upheld a lower court's determination that Medicare statutes do not allow the program to limit reimbursement for a drug under Part B to the rate for a "least costly alternative" drug